Clinical Trial

Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism

Name: Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism — clinical trial record (NCT07245927)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of FORPE Registry is to study the safety and efficacy of the non-immunogenic staphylokinase in patients with massive pulmonary embolism in routine clinical practice.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-17.

Trial Details

NCT Number	NCT07245927
Lead Sponsor	Supergene, LLC Collaborators: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions	Pulmonary Embolism Acute Massive
Enrollment	20,000 participants
Start Date	2025-06-01
Primary Completion	2027-10-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-06